Skye Bioscience, Inc.
SKYE· Nasdaq
SKYESkye Bioscience, Inc.
Filed Nov 9, 2016 · 10-Q · 40 days after period end · 0001640334-16-001933
| Metric | Q3 2016 | Q3 2015 | Q3 2014 | Q3 2013 |
|---|---|---|---|---|
| Net Income | -$945.27K | -$1.18M | -$858.52K | -$30.10K |
| EPS Diluted | -$0.05 | -$0.07 | -$0.08 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Skye Bioscience, Inc. · CIK 1516551 · Engraved from SEC EDGAR
ended Sep 30, 2016 · filed Nov 9, 2016 · 40 d after period end
